WILMINGTON ““ Prelude Therapeutics announced Monday, Oct. 28, that it will expand in Delaware, adding up to 49 biotech positions by 2022 and investing $5 million in expanded lab and office space in the Wilmington ...
Delaware’s aspirations for its high-tech economy are crystallized in people like Yushan Yan. He’s an entrepreneur and University of Delaware professor who is trying to solve a problem with hydrogen fuel cells. Yan and his seven-member ...
Movers, shakers, difference-makers Delaware has plenty of talented people, but who is set to make the biggest impact in 2019? Delaware Business Times asked industry leaders who they thought would be the biggest names in ...
By Dan Linehan Special to Delaware Business Times It’s natural to draw parallels between Kris Vaddi’s time discovering drugs at Incyte, where he spent 14 years, and his latest startup venture, Prelude Therapeutics. But there ...
A founding scientist and previous vice president of the pharmaceutical company Incyte is growing his next venture in Delaware. The state Council on Development Finance (CDF) voted Monday to recommend a performance-based grant package for Prelude Therapeutics. ...
Kris Vaddi has spent enough time in classrooms and laboratories to understand the power of discovery. More importantly, he knows that it cannot be ...
Lessons Learned from a New CEO - After more than a decade of managing a marketing communications agency as a partner and chief creative director, making the step up to CEO shouldn’t
Should I Serve as a Nonprofit Board Treasurer? - The success of a nonprofit organization is largely determined by the passion of its board members and personnel towards their mission. Few opportunit
Giving is Good, Smart Giving is Great! - I’ve been fortunate for the life lessons I was taught by my parents. Both the big ones and the little ones. The one I have the earliest memory of is
DBT40
